Literature DB >> 17073738

Throwing light on DARC.

M Pruenster1, A Rot.   

Abstract

Chemokines play a key role in directing and driving leucocyte trafficking. The efficient regulation of leucocyte recruitment by chemokines requires their appropriate localization in functional micro-anatomical domains, as well as setting limits to their effects in space and time. Both processes are influenced by silent chemokine receptors (interceptors), including DARC (Duffy antigen receptor for chemokines). Increasing experimental evidence suggests that DARC is involved in accumulation of extravascular chemokines in endothelial cells, chemokine transcytosis and presentation on their luminal surface, leading to leucocyte adhesion and emigration. Additionally, DARC is expressed on erythrocytes and can act as a sink for chemokines in blood. This limits the dissemination of chemokines through blood into distant organs and tissues as well as reducing their effects on the circulating leucocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073738     DOI: 10.1042/BST0341005

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  35 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection.

Authors:  Junjie Mei; Yuhong Liu; Ning Dai; Michael Favara; Teshell Greene; Samithamby Jeyaseelan; Mortimer Poncz; Janet S Lee; G Scott Worthen
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

Review 3.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

Review 4.  Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.

Authors:  András N Spaan; Jos A G van Strijp; Victor J Torres
Journal:  Nat Rev Microbiol       Date:  2017-04-19       Impact factor: 60.633

Review 5.  Chemokine receptor oligomerization and allostery.

Authors:  Bryan Stephens; Tracy M Handel
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 6.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 7.  Monocyte-endothelial cell interactions in the development of atherosclerosis.

Authors:  Javier Mestas; Klaus Ley
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

8.  Gene encoding Duffy antigen/receptor for chemokines is associated with asthma and IgE in three populations.

Authors:  Candelaria Vergara; Yuhjung J Tsai; Audrey V Grant; Nicholas Rafaels; Li Gao; Tracey Hand; Maria Stockton; Monica Campbell; Dilia Mercado; Mezbah Faruque; Georgia Dunston; Terri H Beaty; Ricardo Riccio Oliveira; Eduardo V Ponte; Alvaro A Cruz; Edgar Carvalho; Maria Ilma Araujo; Harold Watson; Robert P Schleimer; Luis Caraballo; Renate G Nickel; Rasika A Mathias; Kathleen C Barnes
Journal:  Am J Respir Crit Care Med       Date:  2008-09-30       Impact factor: 21.405

9.  DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines.

Authors:  Jörg Reutershan; Brian Harry; Daniel Chang; Gregory J Bagby; Klaus Ley
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

10.  CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.

Authors:  Julie Catusse; David J Clark; Ursula A Gompels
Journal:  J Inflamm (Lond)       Date:  2009-07-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.